Pharma Equity Group A/S
CSE:PEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Pharma Equity Group A/S
Total Liabilities
Pharma Equity Group A/S
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharma Equity Group A/S
CSE:PEG
|
Total Liabilities
kr13.4m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-8%
|
|
|
Jeudan A/S
CSE:JDAN
|
Total Liabilities
kr26B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
|
Copenhagen Capital A/S
CSE:CPHCAP ST
|
Total Liabilities
kr867.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
P
|
Prime Office A/S
CSE:PRIMOF
|
Total Liabilities
kr3.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Fast Ejendom Danmark A/S
CSE:FED
|
Total Liabilities
kr927.6m
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
|
E
|
EgnsINVEST Ejendomme Tyskland A/S
CSE:EGNETY
|
Total Liabilities
kr850.1m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.
See Also
What is Pharma Equity Group A/S's Total Liabilities?
Total Liabilities
13.4m
DKK
Based on the financial report for Dec 31, 2025, Pharma Equity Group A/S's Total Liabilities amounts to 13.4m DKK.
What is Pharma Equity Group A/S's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
-8%
Over the last year, the Total Liabilities growth was -20%. The average annual Total Liabilities growth rates for Pharma Equity Group A/S have been -19% over the past three years , -10% over the past five years , and -8% over the past ten years .
